# Ipsen BioPharm Ltd, Wrexham, United Kingdom – FDA Inspections

Source: https://www.keypedia.com/companies/ipsen-biopharm-ltd/282b5a9a-91d6-43f7-b345-aa6fede30025

> Inspection records and compliance data for Ipsen BioPharm Ltd in Wrexham. 8 FDA inspections on record, 2 Form 483s, last inspected May 22, 2025.

---

## Details

- Name: Ipsen BioPharm Ltd
- FEI Number: 1000346340
- Address Line 1: Unit 9, Ash Road North
- City: Wrexham
- Country Name: United Kingdom
- Address: Unit 9, Ash Road North, Wrexham, United Kingdom
- Country: United Kingdom

## Related Documents

- FDA Inspection 1283174 - Ipsen BioPharm Ltd - 2025-05-22 — source: FDA, date: May 22, 2025
- [FDA Inspection 1283174 - Ipsen BioPharm Ltd - 2025-05-22](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/896e1ea1-ceca-49a8-b29d-2432591f8ae9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2025
- [FDA Inspection 1117834 - Ipsen BioPharm Ltd - 2019-04-26](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/030c0ad9-b971-4f31-8860-f378e3208168) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 26, 2019
- [FDA Inspection 1059005 - Ipsen BioPharm Ltd - 2018-07-06](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/69366ac8-adf9-4c93-9106-0b8e9dab48c7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 6, 2018
- [FDA Inspection 1026364 - Ipsen BioPharm Ltd - 2017-09-12](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/997abaeb-150c-4efd-9606-322cf0210140) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 12, 2017
- FDA Inspection 965116 - Ipsen BioPharm Ltd - 2016-01-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 20, 2016
- [FDA Inspection 892573 - Ipsen BioPharm Ltd - 2014-07-08](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/375c7919-25f7-4eb3-ac17-4dc023972e9e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 8, 2014
- FDA Inspection 801044 - Ipsen BioPharm Ltd - 2012-09-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2012
- FDA Inspection 675223 - Ipsen BioPharm Ltd - 2010-07-12 — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2010

## Related Companies

- [Lonza Biologics Tuas Pte Ltd](https://www.keypedia.com/companies/lonza-biologics-tuas-pte-ltd/6b75fc9a-7ef0-4669-ae9a-1ac86fbff0f8)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Sanofi-Aventis Deutschland GmbH](https://www.keypedia.com/companies/sanofi-aventis-deutschland-gmbh/07c96432-bb43-45e5-a80d-e4bca284dbab)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)
